Midline Versus Dorsolateral Spinal Cord Stimulation for Post-surgical Neuropathic Pain
- Sponsor
- Nova Scotia Health Authority
- Study ID
- NCT06390150
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Neuropathic Pain
- Pain, Postoperative
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Spinal Cord Stimulator — DEVICEThe spinal cord stimulator is an implantable pulse generator connected to electrodes with leads that stimulate the spinal cord. The device is programmed to deliver therapeutic stimulation to treat pain.
Study Details
The goal of this interventional study is to learn if dorsolateral spinal cord stimulation (DL-SCS) can treat focal post-surgical, medically refractory neuropathic pain. The main question it aims to answer is: \- How does DL-SCS compare to traditional SCS and no treatment for treating post-surgical neuropathic pain? Participants will be asked to * trial combinations of stimulation across blocks of weeks (randomized cross-over) * rate their pain after each stimulation trial
Key Dates
- First listed
- Apr 30, 2024
- Start date
- Sep 30, 2025
- Status verified
- Jul 2025
- Primary completion
- Jun 30, 2028
- Completion
- Jul 31, 2030
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- TREATMENT
Arms
- Experimental: DL-SCS OnlyThe DL-SCS electrode will be activated with a high-frequency paresthesia-free program.
- Placebo Comparator: Stimulation OffBoth electrodes will be programmed for sham stimulation.
- Experimental: M-SCS OnlyThe M-SCS electrode will be activated with a high-frequency, paresthesia free program.
- Experimental: DL-SCS + M-SCSBoth DL-SCS and M-SCS will be activated with high-frequency, paresthesia free programs.
Primary Outcome Measure
Change from baseline on the Numerical Rating Scale (NRS) for pain intensity [ Time Frame: Baseline and at 4, 6, 8, 10, 52, 104 weeks post-surgery ]
Central Contacts
- Lutz Weise, MD, PhD902-472-6850
Related Studies
- Continuous Infusions vs Scheduled Bolus InfusionsPHASE4 · Recruiting · Stanford University · Stanford, California
- Liposomal Bupivacaine Versus Plain Bupivacaine After Intercostal Injections For Pain Management After ThoracoscopyPHASE4 · Recruiting · Milton S. Hershey Medical Center · Hershey, Pennsylvania
- Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic SurgeryPHASE4 · Recruiting · Sanford Health · Fargo, North Dakota
- Pulsed Electromagnetic Field (PEMF) Therapy for Post-operative Pain Following Orthopedic SurgeryRecruiting · Stanford University · Redwood City, California